These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26970432)

  • 1. A win ratio approach to comparing continuous non-normal outcomes in clinical trials.
    Wang D; Pocock S
    Pharm Stat; 2016 May; 15(3):238-45. PubMed ID: 26970432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.
    Pocock SJ; Ariti CA; Collier TJ; Wang D
    Eur Heart J; 2012 Jan; 33(2):176-82. PubMed ID: 21900289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A win ratio approach for comparing crossing survival curves in clinical trials.
    Zheng S; Wang D; Qiu J; Chen T; Gamalo M
    J Biopharm Stat; 2023 Jul; 33(4):488-501. PubMed ID: 36749067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.
    Dong G; Li D; Ballerstedt S; Vandemeulebroecke M
    Pharm Stat; 2016 Sep; 15(5):430-7. PubMed ID: 27485522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted win loss approach for analyzing prioritized outcomes.
    Luo X; Qiu J; Bai S; Tian H
    Stat Med; 2017 Jul; 36(15):2452-2465. PubMed ID: 28343373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphing the Win Ratio and its components over time.
    Finkelstein DM; Schoenfeld DA
    Stat Med; 2019 Jan; 38(1):53-61. PubMed ID: 30206956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilcoxon-Mann-Whitney test: stratify or not?
    Qu Y; Zhao YD; Rahardja D
    J Biopharm Stat; 2008; 18(6):1103-11. PubMed ID: 18991110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted win ratio with stratification: Calculation methods and interpretation.
    Gasparyan SB; Folkvaljon F; Bengtsson O; Buenconsejo J; Koch GG
    Stat Methods Med Res; 2021 Feb; 30(2):580-611. PubMed ID: 32726191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the win odds in the design of non-inferiority clinical trials.
    Peng L
    J Biopharm Stat; 2020 Sep; 30(5):941-946. PubMed ID: 32475213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on the Hodges-Lehmann estimator.
    Rosenkranz GK
    Pharm Stat; 2010; 9(2):162-7. PubMed ID: 19718773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case for omitting tied observations in the two-sample t-test and the Wilcoxon-Mann-Whitney Test.
    McGee M
    PLoS One; 2018; 13(7):e0200837. PubMed ID: 30040850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.
    Bebu I; Lachin JM
    Biostatistics; 2016 Jan; 17(1):178-87. PubMed ID: 26353896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lu TY; Poon WY; Cheung SH
    Stat Methods Med Res; 2015 Dec; 24(6):949-67. PubMed ID: 22267547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
    Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
    J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of inferential methods for the net benefit and win ratio statistics.
    Verbeeck J; Ozenne B; Anderson WN
    J Biopharm Stat; 2020 Sep; 30(5):765-782. PubMed ID: 32097079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.